IDT Corp: Form 10-Q for the period ended Jan 31, 2025
Filed with the SEC on Mar 12, 2025 and accepted by EDGAR at Mar 12, 2025, 15:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-11-01 to 2025-01-31 | $303.3m | us-gaap:Revenues |
| Revenue | 6 months2024-08-01 to 2025-01-31 | $612.9m | us-gaap:Revenues |
| Cost of revenue | 3 months2024-11-01 to 2025-01-31 | $191.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2024-08-01 to 2025-01-31 | $393.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-11-01 to 2025-01-31 | $112.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2024-08-01 to 2025-01-31 | $219.7m | us-gaap:GrossProfit |
| Research and development | 3 months2024-11-01 to 2025-01-31 | $12.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2024-08-01 to 2025-01-31 | $25.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-11-01 to 2025-01-31 | $70.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2024-08-01 to 2025-01-31 | $141.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-11-01 to 2025-01-31 | $28.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-08-01 to 2025-01-31 | $52.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-11-01 to 2025-01-31 | $7.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-08-01 to 2025-01-31 | $14.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-11-01 to 2025-01-31 | $20.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-08-01 to 2025-01-31 | $37.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-11-01 to 2025-01-31 | $0.80 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-08-01 to 2025-01-31 | $1.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-11-01 to 2025-01-31 | $0.81 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-08-01 to 2025-01-31 | $1.49 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-11-01 to 2025-01-31 | 25,324,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-08-01 to 2025-01-31 | 25,343,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-08-01 to 2025-01-31 | $20.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-08-01 to 2025-01-31 | $10.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2024-08-01 to 2025-01-31 | $2.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2024-08-01 to 2025-01-31 | $11.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-01-31 | $142.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-01-31 | $462.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-01-31 | $575.7m | us-gaap:Assets |
| Current liabilities | At period end2025-01-31 | $278.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-01-31 | $280.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-01-31 | $271.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-25-010016. Last ingested by Listed: Nov 4, 2026, 12:50 ET. Listed shows no prices and gives no investment advice.